MANCINA, ROSELLINA MARGHERITA
 Distribuzione geografica
Continente #
AS - Asia 1.283
NA - Nord America 523
SA - Sud America 389
EU - Europa 259
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 2.479
Nazione #
US - Stati Uniti d'America 476
SG - Singapore 390
BR - Brasile 302
HK - Hong Kong 218
CN - Cina 196
VN - Vietnam 150
KR - Corea 139
BD - Bangladesh 113
IT - Italia 90
AR - Argentina 39
FR - Francia 39
GB - Regno Unito 27
ID - Indonesia 22
CA - Canada 20
DE - Germania 20
EC - Ecuador 16
PL - Polonia 14
MX - Messico 13
CO - Colombia 11
IN - India 11
ZA - Sudafrica 10
PY - Paraguay 9
LT - Lituania 8
UA - Ucraina 8
IQ - Iraq 7
RU - Federazione Russa 7
SE - Svezia 7
ES - Italia 6
CH - Svizzera 5
EG - Egitto 5
JP - Giappone 5
NL - Olanda 5
PE - Perù 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
BE - Belgio 4
JM - Giamaica 4
KG - Kirghizistan 4
TR - Turchia 4
EE - Estonia 3
HN - Honduras 3
PK - Pakistan 3
PT - Portogallo 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
GH - Ghana 2
GR - Grecia 2
IE - Irlanda 2
KZ - Kazakistan 2
MA - Marocco 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
VE - Venezuela 2
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
IL - Israele 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
PR - Porto Rico 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.479
Città #
Hong Kong 218
Singapore 152
Seoul 139
Ashburn 90
Chicago 70
Ho Chi Minh City 57
San Jose 52
Beijing 44
Hanoi 29
São Paulo 28
Los Angeles 19
Frankfurt am Main 15
New York 15
Hillsboro 13
Rio de Janeiro 13
Warsaw 13
Dallas 12
Rome 10
Haiphong 9
Guayaquil 8
London 8
Santa Clara 8
Dhaka 7
Montreal 7
Buffalo 6
Da Nang 6
Naples 6
Reston 6
Belo Horizonte 5
Belém 5
Gothenburg 5
Lima 5
Santo André 5
Tashkent 5
Thái Bình 5
Tokyo 5
Toronto 5
Zurich 5
Baghdad 4
Bishkek 4
Boston 4
Brasília 4
Brussels 4
Curitiba 4
Hải Dương 4
Johannesburg 4
Juiz de Fora 4
Mexico City 4
Milan 4
Phoenix 4
Potenza 4
Quito 4
São José dos Campos 4
Araçatuba 3
Betim 3
Bexley 3
Biên Hòa 3
Bogotá 3
Cairo 3
Can Tho 3
Caxias do Sul 3
Cologna Veneta 3
Florence 3
Florianópolis 3
Limburg an der Lahn 3
Manchester 3
Medellín 3
Montevideo 3
Ninh Bình 3
Orem 3
Ottawa 3
Palermo 3
Quilmes 3
Ribeirão Preto 3
Riyadh 3
Rondonópolis 3
San Francisco 3
St Petersburg 3
São José 3
São José do Rio Preto 3
Tallinn 3
Uberlândia 3
Accra 2
Amsterdam 2
Ankara 2
Araguaína 2
Athens 2
Açailândia 2
Bari 2
Bento Gonçalves 2
Boardman 2
Bologna 2
Bratislava 2
Brooklyn 2
Buenos Aires 2
Camaçari 2
Canaã dos Carajás 2
Cape Town 2
Caruaru 2
Chennai 2
Totale 1.293
Nome #
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 81
Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation. 63
Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan 56
PSD3 downregulation confers protection against fatty liver disease 51
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 49
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 48
TM6SF2 and PNPLA3: a potential dynamic duo? 48
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 47
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 46
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 45
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 45
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia 44
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage 44
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 43
Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function 42
Cross talk between liver and adipose tissue: A new role for PNPLA3? 42
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells 42
Cellular Genome-Scale Metabolic Modeling Identifies New Potential Drug Targets Against Hepatocellular Carcinoma 42
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 42
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 41
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity 41
Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels 40
PNPLA3 I148M polymorphism and progressive liver disease 40
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 40
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans 40
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 39
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 39
PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity 38
Genetic variants in the MTHFR are not associated with fatty liver disease 38
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 37
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning 37
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover 37
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 37
ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesity 37
Genome-wide interaction study with BMI identifies CYP7A1 and GIPR as genetic modulators of MASLD 37
Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults 37
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 35
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 35
New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History 35
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 34
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice 33
The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese children 33
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease 33
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes 33
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids 33
Genetic diagnosis of familial hypercholesterolaemia by targeted next‐generation sequencing 33
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals 32
The IRS1 rs2943641 Variant and Risk of Future Cancer Among Morbidly Obese Individuals 31
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome 31
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis 31
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans 31
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 31
High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease 31
Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant 31
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro 31
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 30
Gastrointestinal Symptoms of and Psychosocial Changes in Inflammatory Bowel Disease: A Nursing-Led Cross-Sectional Study of Patients in Clinical Remission 30
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells 29
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans 29
Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children 29
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 28
Statin use and non-alcoholic steatohepatitis in at risk individuals 27
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids 27
Natural Extracts as Modifiers of Intracellular Lipid Handling 27
MBOAT7 is anchored to endomembranes by six transmembrane domains 26
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 24
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with non-alcoholic fatty liver 24
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 23
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia 23
Validation of Interleukin-32 as a new circulating fatty liver biomarker 22
MTARC1 p.A165 ablation reduces hepatocellular carcinoma aggressiveness in vitro and in vivo 6
Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism 4
Totale 2.600
Categoria #
all - tutte 25.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.243


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202467 0 0 0 0 0 0 0 0 30 36 0 1
2024/2025720 19 55 2 9 98 147 76 25 66 38 154 31
2025/20261.790 118 115 299 367 160 26 62 132 152 101 163 95
2026/202723 23 0 0 0 0 0 0 0 0 0 0 0
Totale 2.600